32 results about "Vaccinium myrtillus" patented technology

An antioxidative composition containing: (a) an active component selected from the group consisting of (i) at least two extracts selected from the group consisting of Vaccinium myrtillus, Trifolium pratense, Vitis vinifera and Thea vinensis; (ii) at least two active components selected from the group consisting of anthocyanosides, isoflavone glucosides and polyphenols; and (iii) mixtures thereof; and (b) a co-active component selected from the group consisting tocopherol, ascorbic acid and mixtures thereof.

The invention relates to a method for extracting anthocyanin from Europe vaccinium myrtillus. The method includes the following steps that 1) the Europe vaccinium myrtillus is used as a raw material, reflux extraction is conduct in a 40%-60% ethanol solution, hydrochloric acid is added into the ethanol solution, after an extracting solution is concentrated, a chromatographic column filled with macroporous resin is used, the macroporous resin is washed until effluent is clarified, then a 40%-60% ethanol solution is used for conducting elution, the eluant is collected, concentrated and dried, and then a crude extract is obtained; 2) subcritical extraction is conducted on the crude extract by using acetone as an extraction agent, the injection rate of the extraction agent is one to two times of the weight of the crude extract, the extraction temperature is 58-62 DEG C, the extraction pressure is 2.8-3.2MPa, the extraction time is 20-40min, and after self-volatilized acetone is recycled, a finished product can be obtained. According to the method for extracting the anthocyanin from the Europe vaccinium myrtillus, the processes of ethanol solution reflux extraction, macroporous resin absorption, subcritical extraction and the like are adopted, the steps are simple, the used time is short, the dosage of reagents is small, the yield is about 0.5%, the content of the anthocyanin is about 70%, the yield and the purity are high, and therefore the method is more suitable for industrial production.

The herbal composition for treating diabetes is a mixture of medicinal herbs, including gymnema (Gymnema sylvestre), bilberry (Vaccinium myrtillus), Asian ginseng (Panax ginseng), fenugreek (Trigonella foennum-graecum), marshmallow (Althaea officinalis), “true cinnamon” (also known as “Ceylon cinnamon” or “Sri Lanka cinnamon”) (Cinnamomum verum), bitter melon (also known as “bitter gourd”) (Momordica charantia), autumn crocus (also known as “meadow saffron”) (Colchicum autumnale), bay laurel (Laurus nobilis), colocynth (Citrullus colocynthis) and prickly pear (also known as “cactus pear”) (Opuntia ficus-indica). Preferably, the herbal components of the above composition are dried, ground and packaged in a teabag or the like, allowing the composition to be delivered to the patient as an aqueous extract, similar to a conventional herbal tea. Preferably, about 5 grams of the composition are contained in the teabag, which is steeped in about 150 mL of boiling water for between about three minutes and about five minutes.

An active substance is extracted from an herbal composition which comprises: Centaurii umbellatum, Gentianaceae (centaury plant), Teraxacum officinale, Asteraceae (dandelion root), Juniperi communis L, Cupresaceae (juniper berry), Urticae dioica L, Urticeae (nettle plant), Urticae dioica L, Urticaceae (nettle root), Cichorium intybus L, Cichoriaceae (chicory root), Morus nigra L, Moraceae, (mulberry leaf), Achilleae millefolium L, Asteraceae (yarrow flower), Vaccinium myrtillus L, Ericaceae (bilberry leaf), Phaseolus vulgaris L, Fabaceae (bean pods), Valeriana officinalis L, Valerlanaceae (Valerian root). The active substance is used in the manufacture of pharmaceutical compositions used in connection with control of diabetes mellitus type II.

The invention relates to a vegetable oil composition with an effect of delaying skin aging, and application of the vegetable oil composition. The vegetable oil composition comprises the following components in parts by weight: 25-35 parts of macadamia integrifolia seed oils, 1-3 parts of coffea arabica seed oils, 1-5 parts of sclerocarya birrea seed oils, 1-2 parts of vaccinium myrtillus seed oils, 1-3 parts of adansonia digitata seed oils, 1-5 parts of ginseng radix seed oils, 5-15 parts of simmondsia chinensis seed oils, 5-15 parts of corylus avellana seed oils, 10-20 parts of camellia japonica seed oils, 10-20 parts of Limnanthes Alba seed oils and 2-6 parts of paeonia suffruticosa seed oils. The ultraviolet absorption intensities of the composition are different in the range of 200-400 nm, and the macadamia integrifolia seed oil, the Limnanthes Alba seed oil, the simmondsia chinensis seed oil and the adansonia digitata seed oil have strong ultraviolet absorption in the range of 200-250 nm; the sclerocarya birrea seed oil, the ginseng radix seed oil, the vaccinium myrtillus seed oil, the camellia japonica seed oil, the corylus avellana seed oil and the paeonia suffruticosa seed oil shave relatively strong ultraviolet absorption in the range of 200-300 nm the coffea arabica seed oil has relatively strong ultraviolet absorption in the range of 200-400 nm; and the mixture of the 11 kinds of plant seed oils has a certain absorption effect for the ultraviolet light in the range of 200-400 nm.

The invention relates to the field of plant tissue culture, in particular to rapid propagation culture media for vaccinium myrtillus tissue and a cultivation method of the vaccinium myrtillus tissue, and aims to solve the problem of poor effect of a conventional culture medium on rapid in-vitro propagation of the vaccinium myrtillus tissue. The rapid propagation culture media for the vaccinium myrtillus tissue comprise an axillary bud induction culture medium and a differentiation and proliferation culture medium, wherein the axillary bud induction culture medium is a Dy culture medium containing zeatin, and the differentiation and proliferation culture medium is a Dy culture medium containing 6-benzyl aminopurine and zeatin. The method comprises steps as follows: step one, material selection and sterilization; step two, axillary bud culture as well as differentiation and proliferation. The rapid propagation culture media for the vaccinium myrtillus tissue and the cultivation method of the vaccinium myrtillus tissue are applied to rapid propagation and culture for the vaccinium myrtillus tissue.

The invention discloses a mild exfoliating composition and a preparation method thereof. According to the mild exfoliating composition, aged keratins are effectively softened, the automatic falling of the aged keratins is promoted, the skin is deeply moistened, and the soft and tender skin is restored. The mild exfoliating composition is mainly prepared from the following raw materials in parts by weight: 30-60 parts of sugar maple, 30-60 parts of fructus citri, 20-35 parts of sweet oranges fruits and 20-30 parts of vaccinium myrtillus fruits. The mild exfoliating composition belongs to the cosmetic field.

The invention discloses a multi-effect nursing cosmetic composition for infants. The multi-effect nursing cosmetic composition is prepared by selecting various functional components such as glycosylglycerol, vaccinium myrtillus seed oil, high-molecular-weight sodium hyaluronate, hydrolyzed algae extract, coconut oil alcohol-octoate/caprate and sunflower seed oil unsaponifiable matter, and adding Vernix-Care and three composite skin conditioning components at the same time. The texture improver is supplemented, and all the components cooperate with one another, so that the composition has multiple effects of long-acting moisturizing, relieving and anti-allergy, red skin eliminating and anti-inflammation, itching relieving and repairing and the like, and can be used for quickly and effectively treating sensitive skin symptoms such as infant skin dryness, chap and tension, red apple skin and papule accompanying pruritus and the like. Tests prove that the cosmetic composition disclosed by the invention is high in safety, mild and non-irritant, the skin feeling is soft, comfortable and non-sticky after the cosmetic composition is used, the skin burden of infants is relieved, and the cosmetic composition has a remarkable effect of improving and repairing sensitive skin of the infants.

Cell cultures of Vaccinium myrtillus configured to grow in suspension culture in a liquid medium. The cells are derived from one or more V. myrtillus plant parts, such as an edible plant part (e.g., a leaf part or a berry part) or a stem part. The cells are adapted to grow to a high density is a relatively short period of time (e.g., about 7 days). In addition, the cells are adapted to produce high concentrations of polyphenols and/or procyanidins and essentially no anthocyanin. Methods for production of polyphenols and/or procyanidins from Vaccinium myrtillus cells grown in suspension culture are disclosed.

The invention discloses a method for establishing an European vaccinium callus regeneration system, which comprises the following steps of: inoculating tender branches of European vaccinium seedlings which grow well under a sterile culture condition as explant materials into a culture medium to obtain explants with calluses, and continuously culturing to generate adventitious buds; the formula of the culture medium comprises WPM, 3% of cane sugar, 1% of agar, 0.5 mg/L IBA and 2.0 mg/L ZT, and the pH is 5.2 +/-0.02; when the adventitious buds grow to 2-3 cm, the adventitious buds are moved to a rooting culture medium for rooting induction. The formula of a rooting culture medium is WPM, 2% of sucrose, 1% of agar, 0.3 mg/L of IAA, 1.0 mg/L of KT and 0.50 g/L of activated carbon, and the pH is 5.2 +/-0.02. According to the method disclosed by the invention, the obtaining rates of the callus and the adventitious buds of the vaccinium myrtillus are respectively 100% and 95% or above. According to the method, only 2-3 months are needed from explants to soil cultivation seedling obtaining, and technical support is provided for clone propagation of vaccinium myrtillus.

The invention relates to the field of eye patches, and especially relates to a formula and a preparation technology of a pure traditional Chinese medicinal eye patch mainly used for treating myopia and visual fatigue. The formula of the pure traditional Chinese medicinal eye patch mainly used for treating myopia and visual fatigue comprises, by weight, 120-180 parts of dendrobium, 50-90 parts of white peony root, 90-120 parts of Gambir Plant, 40-70 parts of Spica Prunellae, 50-70 parts of Wild chrysanthemum, 10-20 parts of Herb of Ramose Scouring Rush, 30-40 parts of Fructus Tribuli, 40-70 parts of Salvia miltiorrhiza, 10-30 parts of mint, 20-50 parts of Vaccinium myrtillus and 50-80 parts of Semen Cassiae; and the eye-improving eye patch also contains an auxiliary solution, and the auxiliary solution comprises, by weight, 38 parts of borneol, 38 parts of halitum, 135 parts of pearl hydrolysate and 500 parts of water. Compared with eye patches of the same type, the eye patch produced by adopting a traditional Chinese medicine technology in the invention guarantees the performance of traditional Chinese medicine effects, and has remarkable alleviation effect on myopia, juvenile pseudomyopia, visual fatigue induced by long-term use of mobile phones and computers, and middle-aged and elderly eye discomfort; and the preparation technology is simple and efficient, and is easy to realize large-scale production application.

Disclosed is a method for the identification of Vaccinium myrtillus in a botanical composition and a kit specifically designed for its implementation. The method is based on the detection, using PCR amplification, of nucleic acid fragments within a genomic region of Vaccinium myrtillus.

The invention discloses massage oil capable of rapidly relieving infant erythema, and a preparation method and application of the massage oil. The massage oil is prepared from the following ingredients: caprylic/capric triglyceride, diethylhexyl carbonate, avocado resin, jojoba oil, vaccinium myrtillus seed oil, coconut oil, Inca inchi oil and AC-CHN-P. The invention also provides a preparation method and application of the massage oil. The preparation method comprises the following steps of: step 1, weighing raw materials in proportion, and dividing the raw materials into a phase A and a phase B; step 2, respectively heating the phase A and the phase B, and respectively and uniformly mixing the materials; and step 3, adding the phase B into the phase A under a stirring condition, and uniformly mixing the phase A and the phase B. The phase A comprises caprylic/capric triglyceride, diethylhexyl carbonate, avocado resin and jojoba oil; and the phase B comprises vaccinium myrtillus seed oil, coconut oil, Inca inchi oil and AC-CHN-P. The massage oil disclosed by the invention can be used for pertinently solving skin discomfort caused by infant erythema, and has the functions of promoting skin repair, moisturizing, resisting bacteria, resisting inflammation and the like.

The present invention relates to formulations containing extracts of Vaccinium myrtillus or other species rich in anthocyanosides, Punica granatum, Echinacea, and optionally Krameria triandra. Said formulations are useful in the treatment of disorders of the mouth and its adnexa, the throat and respiratory tract, and in the treatment of influenza.

The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the health of the precorneal film and of the eye surface. This formulation contains an extract of natural origin (Vaccinium myrtillus L) with antioxidant and anti-inflammatory properties; it also uses eicosapentaenoic acid (EPA), omega-6, and docosahexaenoic acid (DHA), omega-3, obtained from fish oil and which, together with lactoferrin, vitamin A and vitamin E, improves tear quality, since these compounds have anti-microbial and anti-inflammatory effects. This formulation has been designed as a coadjuvant for preserving the health of the precorneal film. No formulation for oral administration of a blueberry extract together with lactoferrin, in combination with vitamin A, vitamin E and fish oil (eicosapentaenoic acid and docosahexaenoic acid) is found in the prior art, nor is the use of this formulation as an adjuvant for preserving the health of the precorneal film and/or the eye surface.